These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 6740672)
1. Digestible energy and efficiency of feed utilization in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Seefeld MD; Peterson RE Toxicol Appl Pharmacol; 1984 Jun; 74(2):214-22. PubMed ID: 6740672 [TBL] [Abstract][Full Text] [Related]
2. Relationship of alterations in energy metabolism to hypophagia in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Potter CL; Menahan LA; Peterson RE Fundam Appl Toxicol; 1986 Jan; 6(1):89-97. PubMed ID: 3086171 [TBL] [Abstract][Full Text] [Related]
3. Relationship of the wasting syndrome to lethality in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Christian BJ; Inhorn SL; Peterson RE Toxicol Appl Pharmacol; 1986 Feb; 82(2):239-55. PubMed ID: 3945951 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Seefeld MD; Corbett SW; Keesey RE; Peterson RE Toxicol Appl Pharmacol; 1984 Apr; 73(2):311-22. PubMed ID: 6710531 [TBL] [Abstract][Full Text] [Related]
5. Hypophagia-induced weight loss in mice, rats, and guinea pigs treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Kelling CK; Christian BJ; Inhorn SL; Peterson RE Fundam Appl Toxicol; 1985 Aug; 5(4):700-12. PubMed ID: 4043592 [TBL] [Abstract][Full Text] [Related]
6. Body weight regulation in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Seefeld MD; Keesey RE; Peterson RE Toxicol Appl Pharmacol; 1984 Dec; 76(3):526-36. PubMed ID: 6506077 [TBL] [Abstract][Full Text] [Related]
7. Elevated plasma corticosterone levels and histopathology of the adrenals and thymuses in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats. Gorski JR; Muzi G; Weber LW; Pereira DW; Iatropoulos MJ; Rozman K Toxicology; 1988 Dec; 53(1):19-32. PubMed ID: 3201474 [TBL] [Abstract][Full Text] [Related]
8. Toxicity and evidence for metabolic alterations in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated guinea pigs fed by total parenteral nutrition. Huang Lu CJ; Baggs RB; Redmond D; Henry EC; Schecter A; Gasiewicz TA Toxicol Appl Pharmacol; 1986 Jul; 84(3):439-53. PubMed ID: 3088772 [TBL] [Abstract][Full Text] [Related]
9. Intermediary metabolism of the mature rat following 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. Christian BJ; Menahan LA; Peterson RE Toxicol Appl Pharmacol; 1986 Apr; 83(2):360-78. PubMed ID: 3961820 [TBL] [Abstract][Full Text] [Related]
10. Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Gorski JR; Muzi G; Weber LW; Pereira DW; Arceo RJ; Iatropoulos MJ; Rozman K Toxicol Pathol; 1988; 16(3):313-20. PubMed ID: 3057589 [TBL] [Abstract][Full Text] [Related]
11. Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J and DBA/2J mice. Chapman DE; Schiller CM Toxicol Appl Pharmacol; 1985 Mar; 78(1):147-57. PubMed ID: 4035666 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of pair-feeding and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on various biochemical parameters in female rats. Wahba ZZ; Murray WJ; Hassan MQ; Stohs SJ Toxicology; 1989 Dec; 59(3):311-23. PubMed ID: 2631299 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of intestinal glucose absorption in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Richter E; Hunder G; Forth W Vet Hum Toxicol; 1992 Apr; 34(2):123-6. PubMed ID: 1509671 [TBL] [Abstract][Full Text] [Related]
14. Hypothyroxinemia and hypothermia in rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin administration. Potter CL; Sipes IG; Russell DH Toxicol Appl Pharmacol; 1983 Jun; 69(1):89-95. PubMed ID: 6134353 [TBL] [Abstract][Full Text] [Related]
15. Composition of diet modifies toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in cold-adapted rats. Muzi G; Gorski JR; Rozman K Arch Toxicol; 1987; 61(1):34-9. PubMed ID: 3439872 [TBL] [Abstract][Full Text] [Related]
16. Screening of pharmacological agents given peripherally with respect to TCDD-induced wasting syndrome in Long-Evans rats. Pohjanvirta R; Tuomisto J; Vikkula K Pharmacol Toxicol; 1988 Oct; 63(4):240-7. PubMed ID: 2973575 [TBL] [Abstract][Full Text] [Related]
17. Androgenic deficiency in male rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Moore RW; Potter CL; Theobald HM; Robinson JA; Peterson RE Toxicol Appl Pharmacol; 1985 Jun; 79(1):99-111. PubMed ID: 4049410 [TBL] [Abstract][Full Text] [Related]
18. Studies on the role of lipid peroxidation in the acute toxicity of TCDD in rats. Pohjanvirta R; Sankari S; Kulju T; Naukkarinen A; Ylinen M; Tuomisto J Pharmacol Toxicol; 1990 May; 66(5):399-408. PubMed ID: 2371248 [TBL] [Abstract][Full Text] [Related]
19. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and fasting on body weight and lipid parameters in rats. Schiller CM; Adcock CM; Moore RA; Walden R Toxicol Appl Pharmacol; 1985 Nov; 81(2):356-61. PubMed ID: 4060161 [TBL] [Abstract][Full Text] [Related]
20. Altered regulation of adrenal steroidogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats. DiBartolomeis MJ; Moore RW; Peterson RE; Christian BJ; Jefcoate CR Biochem Pharmacol; 1987 Jan; 36(1):59-67. PubMed ID: 3026405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]